九興控股(01836.HK)首季收入增15.3%至3億美元
九興控股(01836.HK)公布,至3月底止季度,收入為3.034億美元,按年增15.3%,主要由於去年受到新冠肺炎疫情嚴重影響所致之低基數因素。
集團指,對於即將來臨的夏季繼續持審慎樂觀的態度。然而,由於當前主要歐洲國家仍在封城中,下半年的預見度仍低,並取決於新冠肺炎疫情的發展以及全球疫苗接種計畫的進展。
此外,新冠肺炎疫情對於2020年出貨量及產品組合的正常季節性表現有重大影響,這將導致今年餘下時間的季度出貨量在按年的比較上會不一致。
集團將繼續把利潤率提升及實現全年出貨量有穩定增長列為首要任務,藉著充分把握契合集團業務模式及其廣受認可的研發和商業化能力(尤其是與集團運動及奢華類別產品相關)的機遇。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.